Ebola/Marburg vaccine (Crucell/NIAID)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameEbola/Marburg vaccine (Crucell/NIAID)
Drug Alias Namemultivalent filovirus vaccine (recombinant adenoviral vector vaccine) (Crucell/NIAID)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsMarburg Virus DiseaseHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCrucell NV
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCrucell NVNational Institutes Of HealthNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsMarburg Virus DiseaseHemorrhagic Fever, Ebola

Other Information

ATC CodeN/A
Related LinksN/A